Sabra Healthcare Reit Stock Price on December 20, 2024
| SBRA Stock | USD 17.01 0.01 0.06% |
Below is the normalized historical share price chart for Sabra Healthcare REIT extending back to November 08, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sabra Healthcare stands at 17.01, as last reported on the 30th of December, with the highest price reaching 17.09 and the lowest price hitting 16.86 during the day.
If you're considering investing in Sabra Stock, it is important to understand the factors that can impact its price. Sabra Healthcare REIT owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0638, which indicates the firm had a -0.0638% return per unit of risk over the last 3 months. Sabra Healthcare REIT exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sabra Healthcare's Variance of 2.4, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,406) to confirm the risk estimate we provide.
At present, Sabra Healthcare's Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to about 2.4 M, whereas Total Stockholder Equity is forecasted to decline to about 2.1 B. . At present, Sabra Healthcare's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Earnings Ratio is expected to grow to 251.83, whereas Price Earnings To Growth Ratio is projected to grow to (1.94). Sabra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of April 2002 | 200 Day MA 16.3599 | 50 Day MA 18.3288 | Beta 1.235 |
Sabra |
Sharpe Ratio = -0.0638
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SBRA |
Estimated Market Risk
| 1.55 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sabra Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sabra Healthcare by adding Sabra Healthcare to a well-diversified portfolio.
Price Book 1.467 | Enterprise Value Ebitda 16.8457 | Price Sales 5.8937 | Shares Float 233.2 M | Dividend Share 1.2 |
Related Headline
Healthcare Realty Headline on 20th of December 2024
JPMorgan downgraded Healt... HR
Sabra Healthcare Valuation on December 20, 2024
It is possible to determine the worth of Sabra Healthcare on a given historical date. On December 20, 2024 Sabra was worth 16.67 at the beginning of the trading date compared to the closed value of 16.96. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sabra Healthcare stock. Still, in general, we apply an absolute valuation method to find Sabra Healthcare's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sabra Healthcare where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sabra Healthcare's related companies.
| Open | High | Low | Close | Volume | |
| 16.98 | 17.17 | 16.72 | 16.73 | 2,173,772 | |
12/20/2024 | 16.67 | 17.10 | 16.53 | 16.96 | 5,428,307 |
| 16.93 | 17.02 | 16.65 | 16.91 | 1,288,253 |
| Backtest Sabra Healthcare | | | Sabra Healthcare History | | | Sabra Healthcare Valuation | Previous | Next |
Sabra Healthcare Trading Date Momentum on December 20, 2024
| On December 23 2024 Sabra Healthcare REIT was traded for 16.91 at the closing time. The top price for the day was 17.02 and the lowest listed price was 16.65 . The trading volume for the day was 1.3 M. The trading history from December 23, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.29% . The trading price change against the current closing price is 0.35% . |
Sabra Healthcare REIT Fundamentals Correlations and Trends
By evaluating Sabra Healthcare's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sabra financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sabra Healthcare Stock history
Sabra Healthcare investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sabra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sabra Healthcare REIT will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sabra Healthcare stock prices may prove useful in developing a viable investing in Sabra Healthcare
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 232.8 M | 131.1 M | |
| Net Loss | -69.8 M | -66.4 M |
Sabra Healthcare Quarterly Net Working Capital |
|
Sabra Healthcare Stock Technical Analysis
Sabra Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sabra Healthcare Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Sabra Healthcare REIT cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sabra Healthcare December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Sabra Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sabra Healthcare shares will generate the highest return on investment. By undertsting and applying Sabra Healthcare stock market strength indicators, traders can identify Sabra Healthcare REIT entry and exit signals to maximize returns
Sabra Healthcare Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sabra Healthcare's price direction in advance. Along with the technical and fundamental analysis of Sabra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sabra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.16) | |||
| Treynor Ratio | (11.35) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Sabra Stock analysis
When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |